which include the firms’ names, their fields, who bought them in the case of M&As, and the deal value. Once again the data comes courtesy of Dow Jones VentureSource.
*****
Top 10 Massachusetts M&As of 2007 (by purchase price)
Health Dialog (Boston): Decision support services. Acquired by BUPA (United Kingdom) — $775 Million
Adnexus Therapeutics (Waltham): Biotechnology. Acquired by Bristol-Myers Squibb — $430 million
Domantis (Waltham): Biotechnology. Acquired by GlaxoSmithKline — $406 million
Hypnion (Lexington): Pharmaceuticals. Acquired by Eli Lilly — $315 million
Alantos Pharmaceuticals (Cambridge): Biotechnology. Acquired by Amgen — $300 million
VoiceSignal Technologies (Woburn): Connectivity and communications software. Acquired by Nuance Communications — $293 million
Acopia Networks (Lowell): Connectivity and communications software. Acquired by F5 Networks — $210 million
Spotfire (Somerville): Business applications software. Acquired by Tibco Software — $195 million
Interwise (Cambridge): Business applications software. Acquired by AT&T — $121 million
Archivas (Waltham): Database software. Acquired by Hitachi — $120 million
*****
Top 10 Massachusetts IPOs of 2007 (by dollars raised)
Starent Networks (Tewksbury) — Wireless communications equipment — $108 million
Netezza (Framingham) — Data storage — $108 million
Constant Contact (Waltham) — IT business services — $93.3 million
EnerNOC (Boston) — Energy conservation products — $91.7 million
Athenahealth (Watertown) — Decision support services for medical practices — $90 million
TechTarget (Needham) — Media, content & information — $83.6 million (Editor’s note: we applaud all media-content company IPOs, but feel they are all undervalued)
Molecular Insight Pharmaceuticals (Cambridge) — Biotechnology — $70 million
BladeLogic (Lexington) — Connectivity and communications software — $67 million
Virtusa (Westborough) — IT consulting — $61.6 million
Sirtris Pharmaceuticals (Cambridge) — Biotechnology — $60 million
